Abstract
The ability to provide prompt, real-time, easily accessible and radiation-free diagnostic assessments makes ultrasound (US) one of the most versatile imaging modalities. The introduction and development of stable microbubble-based ultrasound contrast agents (UCAs) in the early 1990s improved visualization of complex vascular structures, overcoming some of the limitations of B-mode and Doppler imaging. UCAs have been used extensively in the adult population to visualize vasculature and to evaluate perfusion and blood flow dynamics in organs and lesions. Since the first observations that air bubbles within a liquid can generate a strong echogenic effect, to the early makeshift approaches with agitated saline, and later to the development of industrially produced and federally approved UCAs, these agents have evolved to become both clinically and commercially viable. Perhaps the most exciting potential of UCAs is being uncovered by current research that explores the use of these agents for molecular imaging and therapeutic applications. As contrast-enhanced ultrasound (CEUS) becomes more widely available, it is important for pediatric radiologists to understand the physics of the interaction between the US signal and the microbubbles in order to properly utilize them for the highest level of diagnostic imaging and interventions. In this article we introduce the composition of UCAs and the physics of their behavior in US, and we offer a brief history of their development over the last decades.
Similar content being viewed by others
References
Merritt CRB (2018) Physics of ultrasound. In: Rumack CM (ed) Diagnostic ultrasound, 5th edn. Elsevier, Philadelphia, pp 1–33
Martin K, Ramnarine K (2010) Physics. In: Hoskins PR, Martin K, Thrush A (eds) Diagnostic ultrasound: physics and equipment. Cambridge University Press, Cambridge
Gramiak R, Shah PM (1968) Echocardiography of the aortic root. Investig Radiol 3:356–366
Ziskin MC, Bonakdarpour A, Weinstein DP, Lynch PR (1972) Contrast agents for diagnostic ultrasound. Investig Radiol 7:500–505
Gramiak R, Shah PM, Kramer DH (1969) Ultrasound cardiography: contrast studies in anatomy and function. Radiology 92:939–948
Balen FG, Allen CM, Lees WR (1994) Ultrasound contrast agents. Clin Radiol 49:77–82
Nanda NC (1997) History of echocardiographic contrast agents. Clin Cardiol 20:17–11
Burns PN, Wilson SR (2006) Microbubble contrast for radiological imaging: 1. Principles. Ultrasound Q 22:5–13
Burns PN (2018) Contrast agents for ultrasound. In: Rumack CM (ed) Diagnostic ultrasound, 5th edn. Elsevier, Philadelphia, pp 53–73
Eisenbrey J (2019) Ultrasound contrast agents: Optison. In: Lyshchik A (ed) Specialty imaging: fundamentals of CEUS. Elsevier, Philadelphia, pp 120–123
Eisenbrey J, Hilaire L (2019) Ultrasound contrast agents: Definity. In: Lyshchik A (ed) Specialty imaging: fundamentals of CEUS. Elsevier, Philadelphia, pp 116–119
Eisenbrey J, Greis C (2019) Ultrasound contrast agents: Lumason/SonoVue. In: Lyshchik A (ed) Specialty imaging: fundamentals of CEUS. Elsevier, Philadelphia, pp 110–115
Moran CM (2011) Ultrasonic contrast agents. In: Allan PL, Baxter GM, Weston MJ (eds) Clinical ultrasound, 3rd edn. Churchill Livingstone, Edinburgh, pp 77–89
Forsberg F, Averkiou M, Eisenbrey J (2019) Physical principles of CEUS. In: Lyshchik A (ed) Specialty imaging: fundamentals of CEUS. Elsevier, Philadelphia, pp 92–97
Frinking P, Segers T, Luan Y, Tranquart F (2020) Three decades of ultrasound contrast agents: a review of the past, present and future improvements. Ultrasound Med Biol 46:892–908
Paefgen V, Doleschel D, Kiessling F (2015) Evolution of contrast agents for ultrasound imaging and ultrasound-mediated drug delivery. Front Pharmacol 6:197
Faez T, Emmer M, Kooiman K et al (2013) 20 years of ultrasound contrast agent modeling. IEEE Trans Ultrason Ferroelectr Freq Control 60:7–20
Bove AA, Adams DF, Hugh AE, Lynch PR (1968) Cavitation at catheter tips: a possible cause of air embolus. Investig Radiol 3:159–164
Kremkau FW, Gramiak R, Carstensen EL et al (1970) Ultrasonic detection of cavitation at catheter tips. Am J Roentgenol Radium Therapy, Nucl Med 110:177–183
Ophir J, Parker KJ (1989) Contrast agents in diagnostic ultrasound. Ultrasound Med Biol 15:319–333
Ophir J, Gobuty A, McWhirt RE, Maklad NF (1980) Ultrasonic backscatter from contrast producing collagen microspheres. Ultrason Imaging 2:67–77
Calliada F, Campani R, Bottinelli O et al (1998) Ultrasound contrast agents: basic principles. Eur J Radiol 27:S157–S160
Feinstein SB, Heidenreich PA, Dick CD et al (1988) Albunex: a new intravascular ultrasound contrast agent: preliminary safety and efficacy results. Circulation 78:565
Jablonski EG, Dittrich HC, Bartlett JM, Podell SB (1998) Ultrasound contrast agents: the advantage of albumin microsphere technology. In: Thompson DO, Chimenti DE (eds) Review of progress in quantitative nondestructive evaluation: volume 17A. Springer US, Boston, pp 15–22
Feinstein SB, Cheirif J, Ten Cate FJ et al (1990) Safety and efficacy of a new transpulmonary ultrasound contrast agent: initial multicenter clinical results. J Am Coll Cardiol 16:316–324
Correas JM, Bridal L, Lesavre A et al (2001) Ultrasound contrast agents: properties, principles of action, tolerance, and artifacts. Eur Radiol 11:1316–1328
Schlief R, Schurman R, Niendorf HP (1993) Basic properties and results of clinical trials of ultrasound contrast agents based on galactose. Ann Acad Med Singap 22:762–767
Schurmann R, Schlief R (1994) Saccharide-based contrast agents. Characteristics and diagnostic potential. Radiol Med 87:15–23
No authors (2011) Definity. Highlights of prescribing information. Online document. https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021064s011lbl.pdf. Accessed 23 Mar 2021
GE Healthcare (2016) Optison. Highlights of prescribing information. Online document. http://www3.gehealthcare.com/~/media/documents/MarketoPDFsnogating/OPT-1H-OSLO_Optison_BK. Accessed 23 Mar 2021
Sirsi S, Borden M (2009) Microbubble compositions, properties and biomedical applications. Bubble Sci Eng Technol 1:3–17
Bracco (2020) Lumason. https://imaging.bracco.com/sites/braccoimaging.com/files/technica_sheet_pdf/us-en-2020-01-15-spc-lumason.pdf. Accessed 23 Mar 2021
Lee JY, Minami Y, Choi BI et al (2020) The AFSUMB consensus statements and recommendations for the clinical practice of contrast-enhanced ultrasound using Sonazoid. J Med Ultrasound 28:59–82
Shi WT, Forsberg F, Hall AL et al (1999) Subharmonic imaging with microbubble contrast agents: initial results. Ultrason Imaging 21:79–94
Qin S, Caskey CF, Ferrara KW (2009) Ultrasound contrast microbubbles in imaging and therapy: physical principles and engineering. Phys Med Biol 54:R27–R57
Forsberg F, Gupta I, Machado P et al (2020) Contrast-enhanced subharmonic aided pressure estimation (SHAPE) using ultrasound imaging with a focus on identifying portal hypertension. J Vis Exp. https://doi.org/10.3791/62050
Chong WK, Papadopoulou V, Dayton PA (2018) Imaging with ultrasound contrast agents: current status and future. Abdom Radiol 43:762–772
Starkoff B (2014) Ultrasound physical principles in today’s technology. Australas J Ultrasound Med 17:4–10
Dave JK, Halldorsdottir VG, Eisenbrey JR et al (2012) Noninvasive LV pressure estimation using subharmonic emissions from microbubbles. JACC Cardiovasc Imaging 5:87–92
Eisenbrey JR, Dave JK, Halldorsdottir VG et al (2013) Chronic liver disease: noninvasive subharmonic aided pressure estimation of hepatic venous pressure gradient. Radiology 268:581–588
Gupta I, Eisenbrey JR, Machado P et al (2021) Diagnosing portal hypertension with noninvasive subharmonic pressure estimates from a US contrast agent. Radiology 298:104–111
Nam K, Eisenbrey JR, Stanczak M et al (2017) Monitoring neoadjuvant chemotherapy for breast cancer by using three-dimensional subharmonic aided pressure estimation and imaging with US contrast agents: preliminary experience. Radiology 285:53–62
Sennoga CA, Yeh JSM, Alter J et al (2012) Evaluation of methods for sizing and counting of ultrasound contrast agents. Ultrasound Med Biol 38:834–845
Feshitan JA, Chen CC, Kwan JJ, Borden MA (2009) Microbubble size isolation by differential centrifugation. J Colloid Interface Sci 329:316–324
Sennoga CA, Mahue V, Loughran J et al (2010) On sizing and counting of microbubbles using optical microscopy. Ultrasound Med Biol 36:2093–2096
Segers T, de Jong N, Versluis M (2016) Uniform scattering and attenuation of acoustically sorted ultrasound contrast agents: modeling and experiments. J Acoust Soc Am 140:2506
Guvener N, Appold L, de Lorenzi F et al (2017) Recent advances in ultrasound-based diagnosis and therapy with micro- and nanometer-sized formulations. Methods 130:4–13
Kripfgans OD, Fowlkes JB, Miller DL et al (2000) Acoustic droplet vaporization for therapeutic and diagnostic applications. Ultrasound Med Biol 26:1177–1189
Matsunaga TO, Sheeran PS, Luois S et al (2012) Phase-change nanoparticles using highly volatile perfluorocarbons: toward a platform for extravascular ultrasound imaging. Theranostics 2:1185–1198
Sheeran PS, Luois S, Dayton PA, Matsunaga TO (2011) Formulation and acoustic studies of a new phase-shift agent for diagnostic and therapeutic ultrasound. Langmuir 27:10412–10420
Sheeran PS, Rojas JD, Puett C et al (2015) Contrast-enhanced ultrasound imaging and in vivo circulatory kinetics with low-boiling-point nanoscale phase-change perfluorocarbon agents. Ultrasound Med Biol 41:814–831
Zhang G, Harput S, Hu H et al (2019) Fast acoustic wave sparsely activated localization microscopy (fast-AWSALM): ultrasound super-resolution using plane-wave activation of nanodroplets. IEEE Trans Ultrason Ferroelectr Freq Control 66:1039–1046
Domenici F, Brasili F, Oddo L et al (2019) Long-term physical evolution of an elastomeric ultrasound contrast microbubble. J Colloid Interface Sci 540:185–196
Brown E, Lindner JR (2019) Ultrasound molecular imaging: principles and applications in cardiovascular medicine. Curr Cardiol Rep 21:30
Lindner JR (2004) Molecular imaging with contrast ultrasound and targeted microbubbles. J Nucl Cardiol 11:215–221
Dimcevski G, Kotopoulis S, Bjanes T et al (2016) A human clinical trial using ultrasound and microbubbles to enhance gemcitabine treatment of inoperable pancreatic cancer. J Control Release 243:172–181
Eisenbrey JR, Forsberg F, Wessner CE et al (2021) US-triggered microbubble destruction for augmenting hepatocellular carcinoma response to transarterial radioembolization: a randomized pilot clinical trial. Radiology 298:450–457
Slikkerveer J, Kleijn SA, Appelman Y et al (2012) Ultrasound enhanced prehospital thrombolysis using microbubbles infusion in patients with acute ST elevation myocardial infarction: pilot of the Sonolysis study. Ultrasound Med Biol 38:247–252
Wang Y, Li Y, Yan K et al (2018) Clinical study of ultrasound and microbubbles for enhancing chemotherapeutic sensitivity of malignant tumors in digestive system. Chin J Cancer Res 30:553–563
El Kadi S, Porter TR, van Rossum AC, Kamp O (2020) Sonothrombolysis in the ambulance for ST-elevation myocardial infarction: rationale and protocol. Neth Heart J. https://doi.org/10.1007/s12471-020-01516-9
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
Dr. Eisenbrey has received grant support and speaker fees from Lantheus Medical Imaging, equipment support from Siemens, and grant and equipment support from GE Healthcare. Dr. Forsberg has received equipment support from GE Healthcare, Siemens, Canon and Butterfly; UCA support from Lantheus, GE Healthcare and Bracco; and is a consultant for Samumed and Exact Therapeutics.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Sridharan, A., Eisenbrey, J.R., Forsberg, F. et al. Ultrasound contrast agents: microbubbles made simple for the pediatric radiologist. Pediatr Radiol 51, 2117–2127 (2021). https://doi.org/10.1007/s00247-021-05080-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00247-021-05080-1